Septerna is a biotechnology company dedicated to advancing drug discovery focused on G protein-coupled receptors (GPCRs), which are critical targets in therapeutics. The company’s Native Complex Platform replicates the native structure and dynamics of GPCRs outside cellular environments, facilitating access to modern screening technologies and enabling large-scale drug discovery. Septerna is actively developing a portfolio of small-molecule programs targeting GPCRs that have historically been viewed as undruggable. With a mission to create transformative medicines to address significant patient needs, Septerna fosters an inclusive culture that values diverse perspectives and collaborative teamwork. Employees are encouraged to bring their authentic selves to work, contribute to scientific innovation, and grow alongside a dedicated team of industry professionals.